Nordhealth AS Statistics

Total Valuation

Nordhealth AS has a market cap or net worth of NOK 2.31 billion. The enterprise value is 2.14 billion.

Market Cap	2.31B
Enterprise Value	2.14B

Important Dates

The last earnings date was Tuesday, March 3, 2026.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Nordhealth AS has 80.19 million shares outstanding.

Current Share Class	45.59M
Shares Outstanding	80.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.10%
Owned by Institutions (%)	10.69%
Float	37.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.82
PB Ratio	3.17
P/TBV Ratio	14.86
P/FCF Ratio	n/a
P/OCF Ratio	271.39
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.23
EV / Sales	3.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.25

Financial Position

The company has a current ratio of 2.21

Current Ratio	2.21
Quick Ratio	2.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-283.39

Financial Efficiency

Return on equity (ROE) is -18.76% and return on invested capital (ROIC) is -26.03%.

Return on Equity (ROE)	-18.76%
Return on Assets (ROA)	-10.09%
Return on Invested Capital (ROIC)	-26.03%
Return on Capital Employed (ROCE)	-20.25%
Weighted Average Cost of Capital (WACC)	6.08%
Revenue Per Employee	1.34M
Profits Per Employee	-333,537
Employee Count	450
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, Nordhealth AS has paid 4.60 million in taxes.

Income Tax	4.60M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.61% in the last 52 weeks. The beta is 0.33, so Nordhealth AS's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-23.61%
50-Day Moving Average	33.86
200-Day Moving Average	35.75
Relative Strength Index (RSI)	42.29
Average Volume (20 Days)	74,309

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nordhealth AS had revenue of NOK 604.64 million and -150.09 million in losses.

Revenue	604.64M
Gross Profit	163.16M
Operating Income	-147.58M
Pretax Income	-145.49M
Net Income	-150.09M
EBITDA	-14.04M
EBIT	-147.58M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 174.02 million in cash and n/a in debt, giving a net cash position of 174.02 million or 2.17 per share.

Cash & Cash Equivalents	174.02M
Total Debt	n/a
Net Cash	174.02M
Net Cash Per Share	2.17
Equity (Book Value)	728.60M
Book Value Per Share	n/a
Working Capital	142.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.51 million and capital expenditures -60.28 million, giving a free cash flow of -51.77 million.

Operating Cash Flow	8.51M
Capital Expenditures	-60.28M
Free Cash Flow	-51.77M
FCF Per Share	-0.65

Full Cash Flow Statement

Margins

Gross margin is 26.98%, with operating and profit margins of -24.41% and -24.82%.

Gross Margin	26.98%
Operating Margin	-24.41%
Pretax Margin	-24.06%
Profit Margin	-24.82%
EBITDA Margin	-2.32%
EBIT Margin	-24.41%
FCF Margin	n/a

Dividends & Yields

Nordhealth AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.50%
FCF Yield	-2.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3